Hematologic Disease
17
1
2
13
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
24%
4 trials in Phase 3/4
8%
1 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (17)
Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery
Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors
UNIVERSAL GENETIC TESTING OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (UGT)
Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation
Evaluation of Patients With Blood Disorders
Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients
Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)
Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital
Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A
BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)
Radiologic Features of Invasive Pulmonary Aspergillosis
Safety of Catheter Lock With or Without Heparin in Implanted Central Venous Catheters
Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)
Early Application of CPAP in Hematologic
Functional Evaluation of Two Types of Totally Implanted Venous Ports
Medical Treatment for Diamond Blackfan Anemia
Treatment and Management of Women With Bleeding Disorders